VNDA (STOCKS)
Vanda Pharmaceuticals Inc.
$5.860100
-0.009900 (-0.17%)
Prev close: $5.870000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Mihael Hristos Polymeropoulos
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $353.60M
- Employees
- 368
- P/E (TTM)
- -1.45
- P/B (TTM)
- 1.26
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $217.78M |
| Benefits Costs and Expenses | $367.49M |
| Costs And Expenses | $378.15M |
| Operating Expenses | $378.15M |
| Selling, General, and Administrative Expenses | $256.23M |
| Research and Development | $101.99M |
| Other Operating Expenses | $19.92M |
| Operating Income/Loss | -$160.36M |
| Income/Loss From Continuing Operations After Tax | -$239.55M |
| Income/Loss From Continuing Operations Before Tax | -$149.70M |
| Income Tax Expense/Benefit | $89.84M |
| Income Tax Expense/Benefit, Deferred | $89.24M |
| Net Income/Loss | -$239.55M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$239.55M |
| Net Income/Loss Available To Common Stockholders, Basic | -$239.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.05 |
| Diluted Earnings Per Share | -$4.05 |
| Basic Average Shares | 177,602,339 |
| Diluted Average Shares | 177,602,339 |
| Assets | $433.53M |
| Current Assets | $293.17M |
| Inventory | $1.70M |
| Other Current Assets | $291.47M |
| Noncurrent Assets | $140.36M |
| Fixed Assets | $2.25M |
| Other Non-current Assets | $138.11M |
| Liabilities | $152.76M |
| Current Liabilities | $135.58M |
| Wages | $6.68M |
| Other Current Liabilities | $128.90M |
| Noncurrent Liabilities | $17.18M |
| Equity | $280.77M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $280.77M |
| Liabilities And Equity | $433.53M |
| Net Cash Flow From Operating Activities | -$126.51M |
| Net Cash Flow From Operating Activities, Continuing | -$126.51M |
| Net Cash Flow From Investing Activities | $71.19M |
| Net Cash Flow From Investing Activities, Continuing | $71.19M |
| Net Cash Flow From Financing Activities | -$2.36M |
| Net Cash Flow From Financing Activities, Continuing | -$2.36M |
| Exchange Gains/Losses | -$83.00K |
| Net Cash Flow | -$57.76M |
| Net Cash Flow, Continuing | -$57.68M |
| Comprehensive Income/Loss | -$239.73M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$239.72M |
| Other Comprehensive Income/Loss | $7.95M |
| Other Comprehensive Income/Loss Attributable To Parent | -$171.00K |